Facebook’s late-September Oculus Connect 6 event covered a lot of ground on the future of augmented and virtual reality. This recap will highlight Oculus’s biggest announcements from the AR and VR event, cover the practical applications for patients, and address some ramifications for pharma.
Read More »Tag Archives: pharma
Next-Gen Networks: What 5G Means for Pharma
5G technology promises reduced latency, high speeds, and more connected ecosystems, and has implications in every industry, including healthcare. This POV outlines what 5G is, why industries are rushing to adopt the next-gen tech, and discusses implications for pharma and healthcare brands.
Read More »Andrew’s “Keys to Success for Highly Regulated Industries”: The Highlights
I had the opportunity to speak to SMCKC at the March 2019 breakfast. My presentation, "Keys to Success for Highly Regulated Industries," provided an overview of highly regulated industries, social media best practices, and resources for innovating in regulated spaces. Here are some highlights!
Read More »Beyond the Hype: Six Trends in Artificial Intelligence
There’s been a lot of hype around artificial intelligence (AI) the past few years. If you are still unconvinced of AI’s power and potential, I put together six trends that will be important for AI in the next year and beyond.
Read More »CES 2019: 5G, Self-Driving Cars and “Smart” Everything
2019 was the year that CES was realistic. While there were still some crazy ideas that may not ever make prime time and plenty of dancing robots, most products shown at CES 2019 were not only realistic, but often proven and market ready. Check out this recap!
Read More »AI Summit Recap: Best Practices, Blockchain and More
The AI Summit is one of the world’s largest artificial intelligence (AI) conferences for business. The conference served as a confirmation that AI is not just hype – there are actual business implementations driving real value. Here's my recap!
Read More »GDPR, AI and Machine Learning in the Age of Data Privacy
Over the past few years, there’s been a massive cultural and legal shift in the way consumers view and secure their personal data. Marketers leveraging artificial intelligence (AI) tools might be especially impacted by the trend. Here are a few recommendations for AI marketers.
Read More »Compliant Chatbots on Social: Best Practices for Pharma
The potential for artificial intelligence (AI) in social media and healthcare is incredible, and AI can no longer be relegated to innovation groups. Here are a few considerations for leveraging chatbots compliantly in healthcare.
Read More »Social Trends Pharma Marketers Should Know for 2018
2017 sure kept things interesting. In the fast-changing world of social, each platform has had dozens of updates over the past year. Just like last year, I'm here to review the most important social platform updates and highlight how they will shape social trends in the coming year.
Read More »Twitter’s New Character Limit Means More Freedom for Pharma Marketers
Twitter's famous 140-character limit is no more. The new 280-character tweets will significantly change the way users and marketers will engage on Twitter. This post highlights some of the benefits and considerations for marketers in highly regulated industries.
Read More »What Social Platform Updates Mean For Pharma Marketers in 2017
Many social networks overhauled their platforms in the last year. Here are the most important changes and how they impact the social landscape for pharma marketers.
Read More »Instagram Stories: How Pharma Marketers Can Embrace the New Story Feature
Instagram Stories are here! Though similar to Snapchat Stories, this feature offers marketers many new opportunities. This post will cover how Stories works and address implications for pharma marketers.
Read More »Chatbots Are About to Transform Facebook (And the World)
Chatbots hold a number of potential valuable uses for marketers, including lead generation, point of conversion, retention and customer service. This post addresses what chatbots are, how Facebook is implementing them, and the opportunities and considerations for pharma marketers.
Read More »Open Graph Tags: The Hidden Code That Enables Compliant Social Sharing for Pharma
Understanding the differences between social and organic metadata can help marketers avoid making crucial mistakes. This post will cover what Open Graph tags are, why they are necessary for all websites, and recommendations for pharma marketers based on FDA draft guidance.
Read More »Social Platform Changes: A Barometer for What’s to Come
This post highlights relevant social platform changes to help prepare marketers for what’s to come in 2016, with a focus on pharma. Following are some key trends that have impacted and will continue to impact the way users engage with marketers on social.
Read More »Facebook Users Gain Control With Updated News Feed Options
Facebook’s most recent News Feed update was a change of pace. Instead of updating how the site’s algorithms serve content, more control was placed in the hands of users. This POV will review the updated News Feed controls and how they impact pharma marketers.
Read More »